VANDERBILT UNIVERSITY MEDICAL CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vumc.org
Visualizing Vascular Mechanisms of Salt Sensitivity
Not Applicable
Completed
- Conditions
- Salt; ExcessCardiovascular Risk FactorObesity
- Interventions
- Dietary Supplement: Low-salt dietDietary Supplement: High-salt diet
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT03696433
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Mindfulness to Improve Functional Outcomes in Patients With Fibromyalgia or Central Sensitization
Not Applicable
Terminated
- Conditions
- Chronic PainCentral SensitisationFibromyalgia
- Interventions
- Behavioral: BreathAware for Pain Management
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT03693274
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Discharge Opioid Education to Decrease Opioid Use After Cesarean
Not Applicable
Completed
- Conditions
- Opioid Use
- Interventions
- Other: Opioid Education Handout
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 196
- Registration Number
- NCT03678870
- Locations
- 🇺🇸
Sarah Osmundson, Nashville, Tennessee, United States
Effectiveness of the NoseFrida Compared With Bulb Suction at Relieving Objective Signs of Nasal Obstruction and Reducing Return Visits in Pediatric Patients Presenting to the Emergency Department
Not Applicable
Withdrawn
- Conditions
- Upper Respiratory Tract InfectionsNasal SuctionReturn Emergency Department Visits
- Interventions
- Device: Bulb suctionDevice: NoseFrida
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Vanderbilt University Medical Center
- Registration Number
- NCT03666429
- Locations
- 🇺🇸
Vanderbilt Childrens Emergency Department, Nashville, Tennessee, United States
Switching Medications From Intravenous to Oral
Completed
- Conditions
- Physician's RoleAdministration, Oral
- Interventions
- Other: Clinical Decision Support prompted to the clinician to convert drug.
- First Posted Date
- 2018-09-11
- Last Posted Date
- 2019-10-08
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 921
- Registration Number
- NCT03666520
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Botox or Botox With Esophageal Dilation in Patients With Achalasia
Phase 4
- Conditions
- Achalasia
- Interventions
- Drug: Botulinum toxin type AOther: Patient reported outcomesDevice: Endoscope balloon dilatorDiagnostic Test: Barium esophagram
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03654066
- Locations
- 🇺🇸
Vanderbilt University Medical Center Endoscopy Laboratory, Nashville, Tennessee, United States
Dietary Salt in Rheumatoid Arthritis
Not Applicable
Active, not recruiting
- Conditions
- Rheumatoid Arthritis
- Interventions
- Other: salt
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 22
- Registration Number
- NCT03649178
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Complete Decongestive Therapy With Negative Pressure for Lipedema and Lymphedema Therapy
Not Applicable
Completed
- Conditions
- Secondary LymphedemaLipedema
- Interventions
- Other: CDT with graded negative pressure
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03634462
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Management of Severe Acute Malnutrition in SCD, in Northern Nigeria
Phase 2
Completed
- Conditions
- Sickle Cell AnemiaSevere Acute Malnutrition
- Interventions
- Drug: hydroxyurea (20mg/kg/day)Dietary Supplement: Ready-to-use therapeutic food
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2024-03-27
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 132
- Registration Number
- NCT03634488
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇳🇬Murtala Mohammad Specialist Hospital, Kano, Nigeria
🇳🇬Aminu Kano Teaching Hospital, Kano, Nigeria
Pain Outcomes Following Intralesional Corticosteroid Injections
Phase 4
Completed
- Conditions
- Hypertrophic ScarAlopecia AreataAcneEpidermal Inclusion CystFrontal Fibrosing AlopeciaKeratoacanthomaPlaque PsoriasisKeloidPrurigo NodularisNummular Eczema
- Interventions
- Drug: Corticosteroid with normal salineDrug: Corticosteroid with lidocaine
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 31
- Registration Number
- NCT03630198
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
© Copyright 2025. All Rights Reserved by MedPath